Does SECUKINUMAB Cause Ankylosing spondylitis? 1,942 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,942 reports of Ankylosing spondylitis have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.3% of all adverse event reports for SECUKINUMAB.
1,942
Reports of Ankylosing spondylitis with SECUKINUMAB
1.3%
of all SECUKINUMAB reports
25
Deaths
195
Hospitalizations
How Dangerous Is Ankylosing spondylitis From SECUKINUMAB?
Of the 1,942 reports, 25 (1.3%) resulted in death, 195 (10.0%) required hospitalization, and 47 (2.4%) were considered life-threatening.
Is Ankylosing spondylitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,942 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Ankylosing spondylitis?
CERTOLIZUMAB PEGOL (2,580)
ADALIMUMAB (2,378)
ETANERCEPT (1,456)
METHOTREXATE (1,067)
DICLOFENAC (874)
INFLIXIMAB (789)
GOLIMUMAB (643)
LEFLUNOMIDE (413)
CELECOXIB (329)
SULFASALAZINE (250)
Which SECUKINUMAB Alternatives Have Lower Ankylosing spondylitis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG